The Biosimilars market is projected to grow significantly in the coming years. The market, which was valued at USD 29.1 Bn in 2023, is anticipated to reach USD 122.75 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 15.5% during the forecast period of 2024 to 2033.
The Biologics Contract Manufacturing market is projected to grow significantly in the coming years. The market, which was valued at USD 16.4 Bn in 2023, is anticipated to reach USD 36.40 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 8.3% during the forecast period of 2024 to 2033.
The Acute Myeloid Leukemia market is projected to grow significantly in the coming years. The market, which was valued at USD 1.50 Bn in 2023, is anticipated to reach USD 3.25 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2033.
The Acute Heart Failure (AHF) market is projected to grow significantly in the coming years. The market, which was valued at USD 270.6 Mn in 2023, is anticipated to reach USD 2622.8 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 25.5% during the forecast period of 2024 to 2033.
The Clear Cell HER2 Non-Small Cell Lung Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 5.2 Bn in 2023, is anticipated to reach USD 9.4 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 6.2% during the forecast period of 2024 to 2033.
Crohn's Disease Market size was valued at USD 11.1 Billion in 2022 and is projected to grow from USD 11.5 Billion in 2023 to USD 14.3 Billion by 2030, growing at a compound annual growth rate (CAGR ) by 3.70% over the forecast period (2023 - 2030). One of the major market drivers fueling the expansion of the market is the rising prevalence of Crohn's disease due to changes in people's lifestyles.
Coronary microvascular dysfunction (CMD) refers to a condition characterized by abnormalities in the small blood vessels of the heart, resulting in impaired blood flow to the heart muscle. CMD is a significant health problem because it can lead to chest pain, heart attacks, and heart failure.
Pharmanucleusanalyzes a growth rate of the global congestive heart failure market over the forecast period 2023-2030. The expected CAGR of the global congestive heart failure market tends to be around 7.0% during the mentioned forecast period. The market was valued at USD 21 Billion in 2021, and it will reach USD 36.08 Billion by 2030.
The global protein A resin market in terms of revenue was estimated to be worth $1.2 billion in 2023 and is poised to reach $2.1 billion by 2030, growing at a CAGR of 9.8% from 2023 to 2030The new research study includes a market industry trend analysis. The new study report covers industry trends, price analysis, patent analysis, conference and webinar materials, important stakeholders, and market purchasing behaviour.
It is estimated that the global cold chain market will grow to over US$278.2 billion in 2023 and reach over US$428.4 billion by the end of 2030, with GR 9.0 growth between 2023 and 2030. The globalisation of trade has boosted cross-border goods transit.
The Acute Pancreatitis Market Size was valued at USD 5.5 billion in 2023 and is projected to grow from USD 5.8 Billion in 2023 to USD 8.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.90% during the forecast period (2023 - 2030). The major market driver fueling the expansion is the increased prevalence of gastrointestinal issues.
The Global Acute Ischemic Stroke (AIS) Market is estimated at USD 8,517.0 Million in 2023 and is projected to reach USD 11,185.3 Million by 2030, growing at a CAGR of 4.0% over the forecast period (2023-2030). Acute ischemic stroke (AIS) occurs when blood flow in a cerebral artery is blocked by a clot, which is a thickened mass of blood. Clots are classified as either thrombotic or embolic depending on where they form in the body.
Between 2023 and 2030, the Acute Coronary Syndrome Market is expected to grow significantly. The market will grow at a CAGR of 5.2% from 2023 to 2030, to reach USD 14,810.38 million by 2030, according to Pharmanucleus. An increase in the incidence of chronic diseases such as coronary heart disease, ischemic heart disease, and vascular disease, growing geriatric population, and diverse product offering by market players are the major drivers for the growth of the coronary syndrome market acute.
Viral vector is the most sought-after way to transfer genes to specific cell types or tissues and manipulate them to express therapeutic genes. Currently, there are several types of viruses, such as adenovirus, adeno associated virus, baculovirus and retrovirus, which are being investigated in order to deliver the genes to required cells. This process can provide permanent as well as transient transgene expression.
Oncology Nutrition Market Forecast to 2030 - By Cancer type (Head and Neck Cancers, Stomach and Gastrointestinal Cancers, Lung Cancer, Breast Cancer, Blood Cancer, Other Cancers) and Geography.The term
The parenteral route, commonly referred to as the nasal drug delivery system, is an alternate method of medication administration.The market for nasal drug delivery technology is predicted to expand throughout the course of the forecast period as a result of factors such as rising chronic illness incidence, advanced technology, and rising demand for nasal drug delivery systems. Additionally, it is anticipated that increasing self-administration practises will present more growth opportunities for companies involved in the nasal drug delivery technology market.
Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!
One of our marquee services We profile relevant start-up companies in the market.
Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.
Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.